The Valley Desk

PreprintbioRxivPublished

A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Crossref record name Fox Chase Cancer Center, University of Pennsylvania, The Wistar Institute, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Preprint
Venue
bioRxiv
Published
PubMed ID
42856439
PubMed Central ID
PMC13648573
Added to directory
Source checked

Report a correction or request removal